An external quality assessment scheme for laboratories controlling oral anticoagulant therapy has been available in the Netherlands since 1974.10 Artificially prepared blood specimens have been used because the majority of the participants used the Thrombotest (Nycomed, Oslo, Norway) reagent with citrated blood samples. Thrombotest is a combined reagent containing bovine tissue factor and adsorbed bovine plasma. A substantial number of participants are now using plain tissue factor reagents with plasma for INR determination. These participants can use the same control blood specimens, but they should be centrifuged before being tested.
termined with the three thromboplastin reagents. These differences could not be explained by inaccuracy of the international sensitivity index or mean normal PT of the reagents and must, therefore, have been induced by the preparation procedures for the lyophilised plasmas and control blood samples. The interlaboratory variation of the INR obtained with the calibrant plasma procedure had a coefficient of variation (CV) ranging between 2.1% and 7.3% and tended to be lower than the interlaboratory variation found with the usual methods (3.0-12.2% CV). There was a good agreement between the mean INRs obtained with the calibrant procedure and those obtained using the normal methods. Conclusions-The present study highlights the limitations of some lyophilised plasmas and control blood samples. It is not possible to assign a single INR value to each of these lyophilised plasmas and control specimens that is valid for all thromboplastin reagents. Nevertheless, by using reagent specific INR equivalent values for the calibrant plasma procedure, the interlaboratory variation could be reduced. In some studies the test plasmas were also lyophilised and it is, therefore, not surprising that a substantial reduction of the coefficient of variation was achieved.
An external quality assessment scheme for laboratories controlling oral anticoagulant therapy has been available in the Netherlands since 1974.10 Artificially prepared blood specimens have been used because the majority of the participants used the Thrombotest (Nycomed, Oslo, Norway) reagent with citrated blood samples. Thrombotest is a combined reagent containing bovine tissue factor and adsorbed bovine plasma. A substantial number of participants are now using plain tissue factor reagents with plasma for INR determination. These participants can use the same control blood specimens, but they should be centrifuged before being tested.
In the present field study, five lyophilised plasmas were used for local PT calibration by participants of the Netherlands external quality assessment scheme. Participants were selected on the basis of the reagent used. Only laboratories using the reagents PT-Fib HS, Innovin, or Thromborel-S were included. The purpose of the study was to compare INRs calculated by the participants' usual method with INRs obtained using a lyophilised plasma calibrant procedure.
Methods

REAGENTS
The following thromboplastin reagents were used by the author's laboratory ( For the external quality assessment survey of February 1995, five liquid control blood specimens were prepared, one from pooled normal plasma and four from pooled plasmas of patients treated with coumarin. The pooled plasmas were prepared as described above. Different levels of coumarin effect were selected to represent the therapeutic range of anticoagulation.
Control blood specimens were prepared as described previously,'5 with minor modifications. Erythrocytes were obtained from donor blood (blood group 0) collected in citrate anticoagulant (CPD.A1).'6 The erythrocytes were incubated with a solution containing 8-hydroxyquinoline sulphate, sodium citrate and sodium chloride (pH 6.0) for two hours at room temperature. After centrifugation, the erythrocytes were mixed with the pooled plasmas, aiming at a haematocrit of 42%, and penicillin and streptomycin were added to prevent microbial growth.
After preparation on February 6, 1995 the specimens were posted to 44 participants, together with three vials of each lyophilised plasma. Participants were instructed to analyse the lyophilised plasmas on three days, in duplicate, using their routine PT test method. On the third day (February 10) they analysed one set of lyophilised plasmas and the five control blood specimens.
CALCULATIONS
For each participant, a local calibration line was calculated by orthogonal regression of the log transformed plasma clotting times on the log transformed INR equivalents assigned by the reference laboratory using the appropriate reagent. In general, 30 data points were used for each regression analysis (five plasma calibrants were analysed on three days, in duplicate). All calculations were performed centrally to exclude any possible variation in calculation methods. Using the local calibration line, the clotting times of the blood specimens were transformed to INR equivalents. to be less precise.5 20 A three day local calibration resulted in excellent correlation coefficients (> 0.993) in all laboratories.
There were large and consistent differences between the INRs for the control blood samples determined with the three reagents (tables 4 and 5). Similar differences had been noted in previous external quality assessment surveys. The differences cannot be explained by ISI or MNPT errors and, therefore, must be due to the method of preparation. Control blood samples had a pH of 7.0 (table 5) due to the relatively low pH of red blood cells after treatment with the 8-hydroxyquinoline sulphate solution. Lowering of the pH induces a prolongation of the PT. 14 21 Recent investigations showed that the magnitude of this prolongation is different for the various reagents (van den Besselaar, unpublished data), explaining part of the INR differences reported in tables 4 and 5. The preparation of control blood for the Netherlands external quality assessment scheme may be improved to reduce the INR differences between reagents.
The mean INRs of the control specimens determined with the calibrant procedure (table 4) were in good agreement with the corresponding values determined by the participants' usual procedures (table 5) . This indicates that, on average, there is a good agreement between the calibration by the reference laboratory (on which the assigned calibrant values are based) and the manufacturers' calibration (on which the participants' usual values are based).
Despite the fact that tb.x average values were in good agreement, there was considerable interlaboratory variation with the usual procedures (table 5) . This variation could be reduced substantially with the lyophilised calibrant procedure, particularly for Thromborel-S. A moderate reduction of the interlaboratory variation was observed for PT-Fib HS. The level of interlaboratory variation remaining after local calibration in the present study is similar to the level observed with Thrombotest in a previous study.4
In conclusion, the present study highlights the limitations of lyophilised plasma calibrants and external quality assessment control blood samples. The 
